A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis

Kongnyuy, Michael; Frye, Thomas; George, Arvin; Kilchevsky, Amichai; Iyer, Amogh; Kadakia, Meet; Muthigi, Akhil; Türkbey, Barış; Wood, Bradford J.; Pinto, Peter A.

doi:10.1155/2015/676930

Cited by 5 publications

(3 citation statements)

References 10 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although there is no clear correlation between IBD and prostate cancer, it has been shown that men with UC ulcerative colitis have a higher risk of developing prostate cancer [ 10 ]. While some IBD patients with ileal pouch-anal anastomosis can get transperineal biopsy with ultrasound guidance through the ileal pouch [ 11 , 12 ], it may not always be feasible owing to strictures at the anastomosis. Ultrasound-guided or in-bore transperineal prostate biopsy is an option in this setting but can be challenging due to complexity of the procedure, excessive fibrosis, and limited availability as well as requirement of general anesthesia in case of in-bore transperineal biopsy.…”

Section: Introductionmentioning

confidence: 99%

3.0-T MR-guided transgluteal in-bore-targeted prostate biopsy under local anesthesia in patients without rectal access: a single-institute experience and review of literature

Bera,

Ramaiya,

Paspulati

et al. 2024

Abdom Radiol

View full text Add to dashboard Cite

Purpose To describe the technique and evaluate the performance of MRI-guided transgluteal in-bore-targeted biopsy of the prostate gland under local anesthesia in patients without rectal access. Methods Ten men (mean age, 69 (range 57–86) years) without rectal access underwent 13 MRI-guided transgluteal in-bore-targeted biopsy of the prostate gland under local anesthesia. All patients underwent mp-MRI at our institute prior to biopsy. Three patients had prior US-guided transperineal biopsy which was unsuccessful in one, negative in one, and yielded GG1 (GS6) PCa in one. Procedure time, complications, histopathology result, and subsequent management were recorded. Results Median interval between rectal surgery and presentation with elevated PSA was 12.5 years (interquartile range (IQR) 25–75, 8–36.5 years). Mean PSA was 11.9 (range, 4.8 -59.0) ng/ml and PSA density was 0.49 (0.05 -3.2) ng/ml/ml. Distribution of PI-RADS v2.0/2.1 scores of the targeted lesions were PI-RADS 5–3; PI-RADS 4–6; and PI-RADS 3–1. Mean lesion size was 1.5 cm (range, 1.0–3.6 cm). Median interval between MRI and biopsy was 5.5 months (IQR 25–75, 1.5–9 months). Mean procedure time was 47.4 min (range, 29–80 min) and the number of cores varied between 3 and 5. Of the 13 biopsies, 4 yielded clinically significant prostate cancer (csPca), with a Gleason score ≥ 7, 1 yielded insignificant prostate cancer (Gleason score = 6), 7 yielded benign prostatic tissue, and one was technically unsuccessful. 3/13 biopsies were repeat biopsies which detected csPCa in 2 out of the 3 patients. None of the patients had biopsy-related complication. Biopsy result changed management to radiation therapy with ADT in 2 patients with the rest on active surveillance. Conclusion MRI-guided transgluteal in-bore-targeted biopsy of the prostate gland under local anesthesia is feasible in patients without rectal access.

show abstract

Section: Introductionmentioning

confidence: 99%

3.0-T MR-guided transgluteal in-bore-targeted prostate biopsy under local anesthesia in patients without rectal access: a single-institute experience and review of literature

Bera,

Ramaiya,

Paspulati

et al. 2024

Abdom Radiol

View full text Add to dashboard Cite

show abstract

“…Despite its high precision, in-bore MRI targeted biopsy is not routinely used because it is costly, requires a lot of personnel time, specialized MRI compatible equipment, and discomfort from prone positioning. It may be particularly useful for patients in which TRUS may not be possible such as post-abdominoperineal resection (11). …”

Section: Introductionmentioning

confidence: 99%

Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes

et al. 2016

Self Cite

View full text Add to dashboard Cite

Transrectal ultrasound (TRUS)-guided (12–14 core) systematic biopsy of the prostate is the recommended standard for patients with suspicion of prostate cancer (PCa). Advances in imaging have led to the application of magnetic resonance imaging (MRI) for the detection of PCa with subsequent development of software-based co-registration allowing for the integration of MRI with real-time TRUS during prostate biopsy. A number of fusion-guided methods and platforms are now commercially available with common elements in image and analysis and planning. Implementation of fusion-guided prostate biopsy has now been proven to improve the detection of clinically significant PCa in appropriately selected patients.

show abstract

“…In the article titled “A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis,” [ 1 ] the name of the ninth author was given incorrectly as Brad J. Wood.…”

mentioning

confidence: 99%

A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis

Cited by 5 publications

References 10 publications

3.0-T MR-guided transgluteal in-bore-targeted prostate biopsy under local anesthesia in patients without rectal access: a single-institute experience and review of literature

3.0-T MR-guided transgluteal in-bore-targeted prostate biopsy under local anesthesia in patients without rectal access: a single-institute experience and review of literature

Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes

Corrigendum to “A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis”

Contact Info

Product

Resources

About